Publications

5539 Results

Neoadjuvant zoladex and flutamide in bulky and non-bulky clinical stage C carcinoma of the prostate

Authors
IJ Powell;CM Tangen;GP Haas;D Crawford;GJ Miller;BA Lowe;IM Thompson
Journal / Conference
Journal of Urology 165(5)Suppl:330(#1355)
Year
2001
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-9109

Southwest Oncology Group trial (SWOG) S9718: a phase II study of gemcitabine plus cisplatin in patients with extensive small cell lung cancer (E-SCLC)

Authors
VP Israel;K Chansky;D Gandara
Journal / Conference
Proc of the American Society of Clinical Oncology 20:316a(#1262)
Year
2001
Research Committee(s)
Lung
Study Number(s)
S9718

Encouraging response rate to sequential cyclophosphamide (Cy) followed by fludarbine phosphate (FI) in newly diagnosed B-cell chronic lymphocytic leukemia (CLL): a Southwest Oncolog Group trial.

Authors
MA Hussein;H Gundacker;L Elias;S Dakhil;D Head;F Appelbaum
Journal / Conference
Proc of the American Society of Clinical Oncology 20:305a(#1217)
Year
2001
Research Committee(s)
Leukemia
Study Number(s)
S9706

Phase III trial of protracted infusion (PI) vs intermittent high-dose infusion (HDI) 5-fluorouracil (5-FU) in patients (PTS) with disseminated colorectal cancer (DCRC): a Southwest Oncology Group (SWOG) and Eastern Cooperative Oncology Group (ECOG) study.

Authors
CG Leichman;J Benedetti;H Hochster;M Zalupski;A Benson;J Macdonald
Journal / Conference
Proc of the American Society of Clinical Oncology 20:125a(#497)
Year
2001
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9420

Overall survival after cyclophosphamide, adriamycin, 5-Fu, and tamoxifen (CAFT) is superior to T alone in postmenopausal, receptor (+), node (+) breast cancer: new findings from phase III Southwest Oncology Group Intergroup trial S8814 (INT-0100)

Authors
K Albain;S Green;P Ravdin;C Cobau;E Levine;J Ingle;K Pritchard;D Schneider;M Abeloff;L Norton;D Lew;S Martino;CK Osborne
Journal / Conference
Proc of the American Society of Clinical Oncology 20:24a(#94)
Year
2001
Research Committee(s)
Breast
Study Number(s)
SWOG-8814

Gemcitabine and cisplatin chemotherapy for patients with metastatic or recurrent esophageal carcinoma.

Authors
K Chansky;S Urba;S Taylor;J Paradelo;J Abbruzzese
Journal / Conference
Proc of the American Society of Clinical Oncology 20:161a(#641)
Year
2001
Research Committee(s)
Gastrointestinal
Study Number(s)
S9801

Randomized phase II trial of sequential chemotherapy in advanced non-small cell lung cancer (SWOG 9806): carboplatin/gemcitabine (CARB/G) followed by paclitaxel (P) or cisplatin/vinorelbine (C/V) followed by docetaxel (D).

Authors
MJ Edelman;JI Clark;K Chansky;J Crowley;K Albain;DR Gandara
Journal / Conference
Proc of the American Society of Clinical Oncology 20:314a(#1254)
Year
2001
Research Committee(s)
Lung
Study Number(s)
S9806

Paclitaxel (PCT) and carboplatin (C) with amifostine (A) in advanced or recurrent endometrial cancer: a Southwest Oncology Group trial (S9720).

Authors
SA Scudder;PY Liu;HO Smith;S Wilczynski;EV Hannigan;DS Alberts
Journal / Conference
Proc of the American Society of Clinical Oncology 20:205a(#819)
Year
2001
Research Committee(s)
Gynecologic
Study Number(s)
S9720

Phase III double-blind randomized placebo-controlled study of mifepristone (RU) for the treatment of unresectable meningioma.

Authors
SM Grunberg;C Rankin;J Townsend;J Ahmadi;L Feun;R Fredericks;C Russell;F Kabbinavar;GR Barger;KJ Stelzer
Journal / Conference
Proc of the American Society of Clinical Oncology 20:56a(#222)
Year
2001
Research Committee(s)
Brain
Study Number(s)
SWOG-9005

Phase II evaluation of suramin in advanced adrenal carcinoma: Southwest Oncology Group (SWOG) trial 9427

Authors
L Schroder;T Glass;M Eisenberger;D Culkin;R Bukowski;ED Crawford
Journal / Conference
Proc of the American Society of Clinical Oncology 20:153b(#2361)
Year
2001
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-9427